Triatomic Management’s Insulet PODD Stock Holding History

Triatomic Management’s Portfolio PODD Stock Details PODD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-20,000	Closed	-$3.19M	–	55
2023 Q3	$3.19M	Buy	+20,000	New	+$4.48M	2.2%	15

Other funds holding PODD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Triatomic Management's PODD Position: Q1 2024 in Review

Triatomic Management sold out of Insulet (PODD) in Q1 2024, closing a stake of 7,031 shares — an estimated $1.53M sold.

Triatomic Management first reported a position in PODD in Q4 2021 and held it in 9 quarters. The position peaked at $8.93M in Q1 2022. 563 funds tracked by Wall St. Rank hold PODD as of Q1 2024.

Triatomic Management reported no remaining Insulet position as of Q1 2024 after selling out during the quarter.
Triatomic Management sold 7,031 Insulet shares in Q1 2024, an estimated $1.53M.
Triatomic Management first reported a position in Insulet in Q4 2021 and held it in 9 quarters.
Triatomic Management's Insulet position peaked at $8.93M in Q1 2022.
563 funds tracked by Wall St. Rank held Insulet as of Q1 2024.

Based on Triatomic Management's 13F filing for Q1 2024, filed 13 May 2024.